Avoiding a high fat diet may prevent the LRRK2 gene from triggering Parkinson's

A recent study published in Nature has mapped out how a common genetic risk factor joins forces with a high fat diet to trigger cell exhaustion. Researchers focused on the G2019S variant of the LRRK2 gene, which stands as the most frequent genetic cause of Parkinson's. Because many people who carry this specific mutation never actually develop the condition, scientists have long suspected that a second trigger, such as lifestyle or diet, is required to set the process in motion. To test this two-hit theory, the research team studied mice engineered with the genetic variant. They discovered that even when eating a perfectly normal diet, the mice carrying the mutation experienced a silent, body-wide shortage of pyrimidine nucleosides, specifically thymidine and deoxyuridine. These tiny molecules are crucial because they serve as the fundamental building blocks for repairing and maintaining cellular blueprints. The team traced this shortage back to the liver, where the genetic mutation causes an overproduction of an enzyme called thymidine phosphorylase, which essentially destroys these helpful building blocks before the body can use them. The real damage occurred when the mice were switched to a high fat diet to simulate metabolic syndrome, a cluster of health issues like obesity and high blood sugar. The combination of the genetic mutation and the high fat diet unleashed a severe metabolic crisis, completely disrupting how the brain and lungs manage energy and purine molecules. Looking closely at the midbrain, the researchers pinpointed the exact cells bearing the brunt of this double blow. Astrocytes and oligodendrocytes, the vital support cells that nourish, insulate, and protect our neurons, showed massive failures in their oxidative phosphorylation pathways, meaning their internal power stations could no longer generate energy efficiently. By showing that a high fat diet can exploit a hidden genetic weakness to cause full-body chemical strain and brain cell exhaustion well before visible motor symptoms appear, the study reveals promising new avenues for therapies aimed at protecting metabolic health.